Basel Medical Group Ltd Ordinary Shares Stock (NASDAQ:BMGL)

Revenue Ownership Financials Chart

Previous Close

$5.87

52W Range

$4.60 - $27.36

50D Avg

$6.84

200D Avg

$9.44

Market Cap

$9.97M

Avg Vol (3M)

$62.14K

Beta

0.15

Div Yield

-

BMGL Company Profile

Basel Medical Group Ltd, an entity established in Singapore in 2023, is dedicated to delivering a comprehensive range of healthcare services. Its operations span multiple key areas, including specialist medical expertise, medical supplies and equipment, advanced medical technology solutions, and pharmaceutical products.

Industry

Medical - Care Facilities

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

SG

Employees

70

IPO Date

Feb 25, 2025

Website

BMGL Performance

BMGL Financial Summary

	Jun 24	Jun 23	Jun 22
Revenue	$10.05M	$9.70M	$10.66M
Operating Income	$2.20M	$2.00M	$2.47M
Net Income	$2.07M	$1.78M	$1.98M
EBITDA	$3.11M	$2.93M	$3.28M
Basic EPS	-	$0.10	$0.11
Diluted EPS	-	$0.10	$0.11

Fiscal year ends in Jun 24 | Currency in SGD

Peer Comparison

Ticker	Company
INTS	Intensity Therapeutics, Inc.
IBIO	iBio, Inc.
PIII	P3 Health Partners Inc.
PRPO	Precipio, Inc.
NTRB	Nutriband Inc.
MODD	Modular Medical, Inc.
RBOT	Vicarious Surgical Inc.
TLPH	Talphera, Inc.